snwv20130730_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported)

July 25, 2013 

 

SANUWAVE Health, Inc. 

(Exact name of registrant as specified in its charter)


Nevada 

000-52985 

20-1176000 

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)


11475 Great Oaks Way, Suite 150, Alpharetta, Georgia 

30022 

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code

(678) 581-6843 


N/A 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 8.01          Other Events.

 

On July 25, 2013, SANUWAVE Health, Inc., a Nevada corporation (the “Company”), consummated a public offering of an aggregate of 3,006,818 Units, with each Unit consisting of one share of common stock, par value $0.001 per share (“Common Stock”), together with warrants (the “Warrants”) to purchase up to 1,503,409 shares of Common Stock.  The price per Unit was $0.55 resulting in gross proceeds of $1.65 million. The Company received net proceeds, after payment of the placement agent’s fees, of approximately $1.5 million. The Units separated immediately and the Common Stock and Warrants were issued separately. The Warrants have an exercise price of $0.80 per share and are exercisable during the five-year period beginning on the date of issuance.

 

On July 25, 2013, the Company issued a press release announcing the consummation of the public offering.  A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01          Financial Statements and Exhibits.

 

(d)     Exhibits.

 

Exhibit No.     Description

 

99.1                 Press Release dated July 25, 2013.

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

SANUWAVE HEALTH, INC.

 
       
        
Dated: July 30, 2013 By: /s/ Barry J. Jenkins  
  Name: Barry J. Jenkins  
  Title: Chief Financial Officer  

 

 
 

 

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated July 25, 2013.